BridgeMD
New treatment option for Plantar Fascitis
Official title Plantar Fasciitis Randomized Clinical Control Trial
ClinicalTrials.gov ID: NCT03231150
What this study is testing
- What it's testing
- The primary aim of this clinical experiment is to compare, in terms of pain relief measured using the 10-cm visual analog scale (VAS) pain score (5-7), the clinical results of ultrasound-guided injection (USGI) versus anatomic topography-guided injection (ATGI) of corticosteroid for the treatment of proximal PF. Secondary aims will be to compare foot-related quality of life, as measured using the Foot Function Index (FFI)and the Bristol Foot Score (BFS), between the injection groups, and also to compare the pre-injection to late-term post-injection thickness of the plantar fascia as measured in the nested USGI group.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Pain on palpation along the proximal plantar fascia with or without radiographic evidence of a plantar calcaneal bone spur
- ≥18 years of age
- Male or non-pregnant female of any ethnicity or race
- Active, former or non smoker
- With or without peripheral vascular disease without lower extremity intermittent claudication or rest pain
You likely can't join if
- Known drug or alcohol dependence
- Chronic pain syndrome or lumbosacral radiculitis
- Neurological condition that requires the use of analgesic medications or anti-seizure or neuroleptic medications
- Peripheral vascular disease that results in rest pain or intermittent claudication or venous stasis ulceration
- Calcaneal stress fracture or show evidence of a foreign body or tumor of the affected heel as viewed radiographically
- Pregnant females
See the full eligibility criteria
- Pain on palpation along the proximal plantar fascia with or without radiographic evidence of a plantar calcaneal bone spur
- ≥18 years of age
- Male or non-pregnant female of any ethnicity or race
- Active, former or non smoker
- With or without peripheral vascular disease without lower extremity intermittent claudication or rest pain
- With or without diabetes mellitus without polyneuropathy
- With or without collagen vascular disease without lower extremity wound formation.
- Known drug or alcohol dependence
- Chronic pain syndrome or lumbosacral radiculitis
- Neurological condition that requires the use of analgesic medications or anti-seizure or neuroleptic medications
- Peripheral vascular disease that results in rest pain or intermittent claudication or venous stasis ulceration
- Calcaneal stress fracture or show evidence of a foreign body or tumor of the affected heel as viewed radiographically
- Pregnant females
- Known allergy to any of the components of the injection therapy
- Previously suffered a rupture or surgery of the plantar fascia within the 5 years preceding participation in the investigation
- Existing or prior osteomyelitis of the involved calcaneus
- Unable to consent to participation in clinical research or currently be involved in another clinical investigation.
The study team makes the final eligibility decision.
Where it's taking place
- Philadelphia, Pennsylvania, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Philadelphia, Pennsylvania, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.